Sanofi enters into research collaboration with Audion Therapeutics
16 June 2011 | By Sanofi
Sanofi has entered into a research collaboration with Audion Therapeutics to develop potential treatments for hearing loss...
List view / Grid view
News
Greenphire Partners with Mytrus to provide web-based solutions
16 June 2011 | By The Scott Partnership
Greenphire, partners with Mytrus to deliver novel and efficient web-based solutions for clinical trial patients...
Novartis application for expanded Menveo® indication from 2 months of age accepted for review by FDA
16 June 2011 | By Novartis
The US FDA has accepted for review its supplemental Biologics License Application...
Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients with Chronic Kidney Disease and Type 2 Diabetes
16 June 2011 | By Abbott
Reata and Abbott announced the initiation of a pivotal Phase 3 clinical trial to evaluate the safety and efficacy of bardoxolone methyl in patients with chronic kidney disease and type 2 diabetes...
AstraZeneca extends its investment in Russia with new predictive science centre in St Petersburg
16 June 2011 | By AstraZeneca
AstraZeneca plans to establish a Predictive Science Centre in St. Petersburg...
FDA approves NULOJIX® (belatacept)
16 June 2011 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) approved NULOJIX, the first selective T-cell costimulation blocker indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant, in combination with basiliximab induction, mycophenolate mofetil (MMF), and corticosteroids.
Boehringer Ingelheim & Zealand Pharma enter into a licence & collaboration agreement
16 June 2011 | By Boehringer Ingelheim
For dual-acting glucagon and GLP-1 receptor agonists...
Pfizer Injectables adds doxorubicin hydrochloride injection, USP to its portfolio of off-patent oncology products
15 June 2011 | By Pfizer
Pfizer Injectables, announced the addition of doxorubicin hydrochloride injection, USP...
Tecan and Technical Communities sign new government services partnership agreement
14 June 2011 | By kdm communications limited
Technical Communities to distribute Tecan’s liquid handling platforms...
Horizon successfully completes pilot human gene-editing program
14 June 2011 | By Zyme Communications Ltd
Horizon Discovery has announced that it has successfully completed an eighteen month pilot program with Novartis...
Abbott receives FDA approval for CREON® (pancrelipase) infant-specific dosage
14 June 2011 | By Abbott
The U.S. FDA approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat EPI due to cystic fibrosis...
GSK to purchase Shenzhen Neptunus stake in previously formed joint venture for influenza vaccines in China
14 June 2011 | By GlaxoSmithKline
GSK to acquire the remaining 51% equity interest of Shenzhen Neptunus...
Corning hires biotechnology expert as leader of Corning Life Sciences
13 June 2011 | By Corning Incorporated
Corning Inc., has hired Dr. Richard Eglen, as vice president and general manager of the Corning Life Sciences business segment...
Gilead Sciences’ Kevin Young appointed a Commander of The British Empire
13 June 2011 | By Gilead Sciences, Inc.
Gilead Sciences, Inc. is pleased to announce that Kevin Young, has been appointed a Commander of The British Empire...
Merck and Hanwha Chemical Corporation establish global strategic collaboration
13 June 2011 | By Merck
Merck and Hanwha Chemical Corporation to develop and commercialize a candidate biosimilar form of Enbrel® (etanercept)....
